Vedere Bio II
Latest round
- Series A
Last raised
- May 2021
Total raised
- $98M
Investors
- 7
About Vedere Bio II
Based in Massachusetts, US, and founded in 2019, Vedere Bio II, Inc. biotech company that is developing next-generation ocular gene therapies for vision restoration. Cyrus D.D. is the co-founder, current CEO, and President of the company. The company is funded by Atlas Venture, Casdin Capital, Mission BioCapital, Octagon Capital, the RD Fund, and Samsara BioCapital. In March 2023, Vedere Bio II, Inc. discontinued its operations. The company offers ocular gene therapies that include an optogenetics-based platform called ‘mutation-agnostic’ technology and novel AAV capsids to restore eyesight in all patients who have lost vision owing to photoreceptor cell death. The company also offers proprietary intravitreally-administered adeno-associated virus (AAV) vectors that enable office-based treatment on a global scale.
Who invested in Vedere Bio II
7 investors across 2 rounds
See all investors in Vedere Bio II
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vedere Bio II
Who invested in Vedere Bio II?
Vedere Bio II has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vedere Bio II raised?
Vedere Bio II has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vedere Bio II last raise money?
Vedere Bio II's most recent round on record is a Series A, in May 2021.
What does Vedere Bio II do?
Based in Massachusetts, US, and founded in 2019, Vedere Bio II, Inc.
Where is Vedere Bio II headquartered?
Vedere Bio II is headquartered in Cambridge, US.
Which VCs invest in companies like Vedere Bio II?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vedere Bio II's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vedere Bio II? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.